Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

UC Davis Utilizes GenomeQuest Solution to ID Virus

Sat. November 15, 2008; Posted: 01:16 AM
Stocks RSS
IFCPF | Quote | Chart | News | PowerRating -- GenomeQuest, a provider of sequence informatics, announced researchers at the University of California, Davis used its recently announced On-Demand Informatics Solution to process and analyze next-generation sequencing data, successfully leading to identification of a new RNA virus from a declining Syrah grapevine cultivar.

The virus-hunting project was led by UC Davis researchers from Dr. Adib Rowhani's lab, under the supervision of Dr. Maher Al Rwahnih. The researchers traced the composition and origin of a previously unknown virus that was suspected of causing a declining disease in California Syrah vineyards. This work supports efforts to help the wine industry with vineyard management and grape production.

The researchers used the Roche 454 platform to generate massive data files representing genetic material from samples of healthy and diseased plants. The GenomeQuest team, under the supervision of Dr. Jean-Jacques Codani, adapted a bioinformatics workflow to compute, from raw sequence data, a valuable database by grouping and classifying sequences that had high similarity to known organisms. Sequences that did not have a match were grouped in such a manner that helped the researchers to find similarity between potential hidden viruses and known viruses. UC Davis researchers were then able to access the database via the GenomeQuest web interface to select suspect sequences that did not have high similarities to known organisms, but had kinship with known viruses - ultimately identifying the elusive viral culprit by matching the sequences against those in the specialized viral database. (The UC Davis team will be publishing their findings in an edition of an upcoming peer reviewed journal.)

Dr. Adib Rowhani at UC Davis, said, "This successful identification of the suspected organism is truly groundbreaking research which will be of great practical benefit to the California wine industry - a fact that is a source of great pride to our UC Davis-based team."

Dr. Jean-Jacques Codani, Chief Scientific Officer of GenomeQuest, said "We are pleased when our platform enables researchers to perform good science. The search for the suspect virus generated a vast volume of sequence data. Our accurate algorithms and interactive GenomeQuest software platform was instrumental in reducing a time-prohibitive computational search and analysis problem into a very efficient and streamlined process. This enabled us to quickly obtain usable output. The success of the UC Davis research team shows that we are at a turn in the genomics revolution whereby scientific problems previously thought to be economically or computationally intractable are now within reach."

((Comments on this story may be sent to newsdesk@closeupmedia.com))

((Distributed via M2 Communications Ltd - http://www.m2.com))

http://www.10meters.com

Comments on this story may be sent to newsdesk@closeupmedia.com

For full details for IFCPF click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [IFCPF]
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.